ArticleAnnals of cardiothoracic surgery2025
Transcatheter aortic valve replacement explant various techniques.
Article in Annals of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Minimally Invasive TAVR Explantation and Aortic Valve Replacement in a Patient With a Retrosternal Conduit.JACC. Case reports · 2026Article
- TAVR Explant in the Era of Lifetime Valve Management: Indications, Operative Challenges, and Contemporary Outcomes.Current cardiology reports · 2026Review
- Contemporary Management of Aortic Stenosis: Timing of Intervention and Lifetime Valve Management.European journal of clinical investigation · 2026Review
- Paradoxical sparing of cerebral circulation in massive TAVR-associated endocarditis.Journal of cardiothoracic surgery · 2026Article
- Gradients after transcatheter aortic valve replacements are impacted by both body mass index and valve size: a retrospective cohort study.Cardiovascular diagnosis and therapy · 2026Article
- Temperature-triggered nitinol manipulation for explantation of self-expanding transcatheter aortic valves: a case report.Journal of cardiothoracic surgery · 2026Article
- Managing Transcatheter Aortic Valve Failure.Structural heart : the journal of the Heart Team · 2026Review
- Early Predictors of Surgical Explantation of Transcatheter Aortic Valve Replacement: A Multi-Center International Database Analysis.Journal of clinical medicine · 2026Article
- Surgical vs. Medical Management of Infective Endocarditis Following TAVR: A Systematic Review and Meta-Analysis.Journal of cardiovascular development and disease · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical aortic valve replacement (SAVR) has long been the gold standard for treating significant aortic valve dysfunction. Since the introduction of transcatheter aortic valve replacement (TAVR) in 2011, the number of TAVRs has grown rapidly, surpassing SAVR volumes by 2018 and now accounting for approximately 80% of all aortic valve replacements (AVRs) performed in the United States. In conjunction with the rapid expansion of TAVR, the number of TAVR valves requiring surgical explantation (TAVR-explant) has also increased due to procedure-related failure, endocarditis, structural valve degeneration with unfavorable anatomy for redo-TAVR, paravalvular leak, delayed migration, or prosthesis-patient mismatch. Often involving concomitant cardiac surgery, TAVR-explant has been associated with higher operative mortality than redo-SAVR. TAVR-explant is currently the fastest-growing cardiac procedure in the United States and is expected to continue growing, especially as TAVR is increasingly used for lower surgical risk and younger patients. Accordingly, describing and disseminating a standardized set of technical principles for performing TAVR-explant is essential for preparing all cardiac surgeons to appropriately treat these patients. TAVR-explant requires a comprehensive preoperative clinical and cross-sectional imaging assessment to plan an effective operation, including cannulation, aortotomy, explantation, and implantation strategies. Particular considerations for self-expanding and balloon-expandable TAVR valves are important for guiding the operation and optimizing outcomes. Special considerations, such as the need for concomitant aortic, coronary, or mitral valve surgery and the presence of snorkel coronary artery stents adjacent to the TAVR valve, must be considered and addressed at the time of TAVR-explant surgery. Currently, TAVR-explant confers a high operative mortality and is performed at very low volumes per surgeon. As this operation becomes increasingly common, it will become essential for all cardiac surgeons to understand and implement the operation's various techniques to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.